Viral Vector Manufacturing And Cell Harvesting From A Single Bioreactor?

Both cell-based and gene therapies, including viral vector manufacturing, require a volume that is not easy to achieve in traditional planar adherent cell culture environments. Researchers and commercial producers are now looking at fixed bed reactor (FBR) technology to support growth and scalability in upstream bioprocessing.

To address the need for a higher density adherent cell culture platform, we developed the Corning^® Ascent™ FBR system. The platform offers automated recirculating bioproduction that not only supports scalability, but also provides flexibility in process development. Explore how this closed system can be used outside a laminar flow hood for both adherent cell harvesting and cell product capture.